Abstract 192: Scleraxis is a Required Component of the Cardiac Extracellular Matrix Gene Expression Program
Michael P. Czubryt(St. Boniface Hospital), Ronen Schweitzer(Oregon Health & Science University), Shreyas Devalapurkar(University of Manitoba), Patricia Roche(St. Boniface Hospital), Rushita A. Bagchi(University of Colorado Anschutz Medical Campus), Ryan Wang(University of Manitoba)
Cited by 1
Related Papers
MEF2C Transcription Factor Controls Chondrocyte Hypertrophy and Bone Development
|Developmental Cell|2007|457
Regulation of peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) and mitochondrial function by MEF2 and HDAC5
|Proceedings of the National Academy of Sciences|2003|419
Requirement for serum response factor for skeletal muscle growth and maturation revealed by tissue-specific gene deletion in mice
|Proceedings of the National Academy of Sciences|2005|296
Cardiac Fibroblast Activation Post-Myocardial Infarction: Current Knowledge Gaps
|Trends in Pharmacological Sciences|2017|204
Targeting the renin-angiotensin-aldosterone system in fibrosis
|Matrix Biology|2020|187